BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22845427)

  • 21. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
    Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
    Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.
    Gunnell AS; Hung J; Knuiman MW; Nedkoff L; Gillies M; Geelhoed E; Hobbs MS; Katzenellenbogen JM; Rankin JM; Ortiz M; Briffa TG; Sanfilippo FM
    Cardiovasc Ther; 2016 Dec; 34(6):423-430. PubMed ID: 27489053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
    Griffiths B; Lesosky M; Ntsekhe M
    S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes.
    Moriel M; Tzivoni D; Behar S; Zahger D; Hod H; Hasdai D; Sandach A; Gottlieb S
    Int J Cardiol; 2008 Dec; 131(1):97-104. PubMed ID: 18222551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiology of acute coronary syndrome in the City of Zagreb].
    Heim I; Jonke V; Gostović M; Jembrek-Gostović M
    Acta Med Croatica; 2009 Feb; 63(1):105-9. PubMed ID: 19681474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-hospital prescriptions of secondary-prevention medications for post-acute coronary syndrome patients in South Korea
.
    Kang HB; Choi M; Yoon SG; Cho YS; Je NK
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):1-11. PubMed ID: 29168689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of cardiovascular risk factors and management practices of acute coronary syndrome in a tertiary care hospital.
    Dilip C; Cholamugath S; Baby M; Pattani D
    J Basic Clin Physiol Pharmacol; 2015 Nov; 26(6):547-54. PubMed ID: 26280167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quality guarantee in acute coronary syndromes: the American College of Cardiology's Guidelines Applied in Practice program taken real-time.
    Vasaiwala S; Nolan E; Ramanath VS; Fang J; Kearly G; Van Riper S; Kline-Rogers E; Otten R; Cody RA; Eagle KA
    Am Heart J; 2007 Jan; 153(1):16-21. PubMed ID: 17174631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of evidence-based management for acute coronary syndrome.
    Tang E; Wong CK; Wilkins G; Herbison P; Williams M; Kay P; Restieaux N
    N Z Med J; 2005 Oct; 118(1223):U1678. PubMed ID: 16224502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-to-practice gaps in the management of community-dwelling Australian patients with ischaemic heart disease.
    Schmid O; Chalmers L; Bereznicki L
    J Clin Pharm Ther; 2015 Aug; 40(4):398-403. PubMed ID: 25924028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study.
    Lopez-Carmona D; Bernal-Lopez M; Mancera-Romero J; Jansen-Chaparro S; Portales-Fernandez I; Baca-Osorio AJ; Perez-Gonzalez R; Tinahones FJ; Gomez-Huelgas R
    Eur J Prev Cardiol; 2012 Oct; 19(5):1074-81. PubMed ID: 21810843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR).
    Zeymer U; Berkenboom G; Coufal Z; Belger M; Sartral M; Norrbacka K; Bakhai A;
    Int J Cardiol; 2013 Dec; 170(2):239-45. PubMed ID: 24225199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq.
    Nassr OA; Forsyth P; Johnson CF
    Pharm Pract (Granada); 2019; 17(1):1372. PubMed ID: 31015874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure.
    Brackbill ML; Bashaw-Keaton R; Sytsma CS
    Am J Manag Care; 2007 Oct; 13(10):568-70. PubMed ID: 17927461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.
    Tricoci P; Roe MT; Mulgund J; Newby LK; Smith SC; Pollack CV; Fintel DJ; Cannon CP; Bhatt DL; Gibler WB; Ohman EM; Peterson ED; Harrington RA
    Arch Intern Med; 2006 Apr; 166(7):806-11. PubMed ID: 16606819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide audit.
    Ellis C; Gamble G; French J; Devlin G; Matsis P; Elliott J; Mann S; Williams M; White H;
    N Z Med J; 2004 Jul; 117(1197):U953. PubMed ID: 15326506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.